Patents by Inventor Jesse Daniel Keicher

Jesse Daniel Keicher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170333494
    Abstract: Aspects of the present invention are related to the use of Lactobacillus species in a composition for respiratory administration to prevent the pathogenic inflammatory sequelae of respiratory virus infections.
    Type: Application
    Filed: November 9, 2015
    Publication date: November 23, 2017
    Inventors: David A. WILFRET, Jesse Daniel KEICHER, Helene Fischer ROSENBERG
  • Publication number: 20140249143
    Abstract: Provided are certain compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections.
    Type: Application
    Filed: October 19, 2012
    Publication date: September 4, 2014
    Applicant: GlaxoSmithKline LLC
    Inventors: Anna Lindsey Banka, Janos Botyanszki, Eric Gregory Burroughs, John George Catalano, Wendy Huang Chern, Hamilton D. Dickson, Margaret J. Gartland, Robert Hamatake, Hans Hofland, Jesse Daniel Keicher, Christopher Brooks Moore, John Bradford Shotwell, Matthew David Tallant, Jean-Philippe Therrien, Shihyun You
  • Publication number: 20110044943
    Abstract: Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Application
    Filed: July 11, 2008
    Publication date: February 24, 2011
    Inventors: Martin Robert Leivers, Jesse Daniel Keicher, Franz Ulrich Schmitz, Roopa Rai, Ryan Lauchli, Sebastian Reinhard Johannes Liehr, Stephanie Anna Chan, Tony Loc Ton
  • Publication number: 20090253648
    Abstract: Disclosed are compounds represented by formulae I, II, and III, and the compositions and methods thereof for treating viral infections caused by a Flaviviridae family virus.
    Type: Application
    Filed: March 31, 2009
    Publication date: October 8, 2009
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts, Sebastian Johannes Reinhard Liehr, Xiaoling Zheng, Marija Prhavc, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Choung U. Kim
  • Publication number: 20090208457
    Abstract: Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.
    Type: Application
    Filed: March 31, 2009
    Publication date: August 20, 2009
    Applicant: SMITHKLINE BEECHAM CORPORATION
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts
  • Publication number: 20090197880
    Abstract: Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Application
    Filed: January 12, 2009
    Publication date: August 6, 2009
    Inventors: Martin Robert Leivers, Jesse Daniel Keicher, Franz Ulrich Schmitz, Roopa Rai, Ryan Lauchli, Sebastian Reinhard Johannes Liehr, Stephanie Anna Chan, Tony Loc Ton, Son Minh Pham, Adam Christopher Villa
  • Patent number: 7534771
    Abstract: Disclosed are compounds, compositions and methods for treating viral infections caused by a Flaviviridae family virus, such as hepatitis C virus.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: May 19, 2009
    Assignee: SmithKline Beecham Corporation
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts
  • Patent number: 7524825
    Abstract: Disclosed are compounds represented by formulae I, II, and III, and the compositions and methods thereof for treating viral infections caused by a Flaviviridae family virus.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: April 28, 2009
    Assignee: SmithKline Beecham Corporation
    Inventor: Jesse Daniel Keicher
  • Publication number: 20090074717
    Abstract: Disclosed are compounds of Formula (I), pharmaceutically acceptable salts and solvates thereof, compositions thereof, and methods for their preparation and uses for treating viral infections mediated at least in part by a virus in the Flaviviridae family of viruses.
    Type: Application
    Filed: July 11, 2008
    Publication date: March 19, 2009
    Inventors: Martin Robert Leivers, Jesse Daniel Keicher, Franz Ulrich Schmitz, Roopa Rai, Ryan Lauchli, Sebastian Reinhard Johannes Liehr, Stephanie Anna Chan, Tony Loc Ton
  • Publication number: 20090062223
    Abstract: Provided are compounds of Formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds and compositions are useful for treating viral infections caused by the Flaviviridae family of viruses.
    Type: Application
    Filed: August 29, 2008
    Publication date: March 5, 2009
    Inventors: Jesse Daniel Keicher, Christopher Don Roberts, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Xiaoling Zheng, Sebastian Johannes Reinhard Liehr, Marija Prhavc, Choung U. Kim, Adrian S. Ray
  • Publication number: 20090048189
    Abstract: Disclosed are tricyclic nucleoside compounds of formula (I), and methods thereof for treating viral infections mediated at least in part by a Flaviviridae family virus.
    Type: Application
    Filed: August 15, 2007
    Publication date: February 19, 2009
    Inventors: Jesse Daniel KEICHER, Christopher Don Roberts, Sebastian Johannes Reinhard Liehr, Xiaoling Zheng, Marija Prhavc, Vivek Kumar Rajwanshi, Ronald Conrad Griffith, Choung U. Kim
  • Patent number: 6951880
    Abstract: This invention provides novel compounds possessing antibacterial and/or antifungal and/or antitumor activity. Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds are also provided.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: October 4, 2005
    Assignee: Genelabs Technologies, Inc.
    Inventors: Christoher Don Roberts, Jesse Daniel Keicher, Mikail Hakan Gezginci, Mark Douglas Velligan
  • Publication number: 20030220340
    Abstract: This invention provides novel compounds possessing antibacterial and/or antifungal and/or antitumor activity. Pharmaceutical compositions containing these compounds, methods of making and methods for using these compounds are also provided.
    Type: Application
    Filed: May 15, 2003
    Publication date: November 27, 2003
    Inventors: Christoher Don Roberts, Jesse Daniel Keicher, Mikail Hakan Gazginci, Mark Douglas Velligan